A detailed history of Morgan Stanley transactions in Alector, Inc. stock. As of the latest transaction made, Morgan Stanley holds 4,355,770 shares of ALEC stock, worth $8.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,355,770
Previous 3,005,073 44.95%
Holding current value
$8.36 Million
Previous $13.6 Million 49.09%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.34 - $6.58 $5.86 Million - $8.89 Million
1,350,697 Added 44.95%
4,355,770 $20.3 Million
Q2 2024

Oct 17, 2024

SELL
$4.19 - $6.23 $1.26 Million - $1.87 Million
-299,903 Reduced 9.07%
3,005,073 $13.6 Million
Q2 2024

Aug 14, 2024

SELL
$4.19 - $6.23 $1.26 Million - $1.87 Million
-299,903 Reduced 9.07%
3,005,073 $13.6 Million
Q1 2024

Oct 17, 2024

BUY
$5.69 - $8.08 $1.71 Million - $2.42 Million
299,903 Added 9.98%
3,304,976 $19.9 Million
Q1 2024

Aug 16, 2024

SELL
$5.69 - $8.08 $7.65 Million - $10.9 Million
-1,345,215 Reduced 28.93%
3,304,976 $19.9 Million
Q1 2024

May 15, 2024

SELL
$5.69 - $8.08 $7.65 Million - $10.9 Million
-1,345,215 Reduced 28.93%
3,304,976 $19.9 Million
Q4 2023

Aug 16, 2024

BUY
$3.77 - $8.39 $6.2 Million - $13.8 Million
1,645,118 Added 54.74%
4,650,191 $37.1 Million
Q4 2023

Feb 13, 2024

BUY
$3.77 - $8.39 $4.95 Million - $11 Million
1,312,805 Added 39.34%
4,650,191 $37.1 Million
Q3 2023

Nov 15, 2023

BUY
$5.2 - $8.77 $8.35 Million - $14.1 Million
1,605,293 Added 92.68%
3,337,386 $21.6 Million
Q2 2023

Aug 14, 2023

BUY
$5.86 - $7.93 $7.52 Million - $10.2 Million
1,283,131 Added 285.8%
1,732,093 $10.4 Million
Q1 2023

May 15, 2023

SELL
$5.85 - $9.84 $854,088 - $1.44 Million
-145,998 Reduced 24.54%
448,962 $2.78 Million
Q4 2022

Feb 14, 2023

BUY
$6.88 - $9.55 $160,145 - $222,295
23,277 Added 4.07%
594,960 $5.49 Million
Q3 2022

Nov 14, 2022

SELL
$8.19 - $13.2 $1.98 Million - $3.2 Million
-242,189 Reduced 29.76%
571,683 $5.41 Million
Q2 2022

Oct 27, 2022

BUY
$7.65 - $14.24 $1.51 Million - $2.81 Million
197,256 Added 31.99%
813,872 $8.27 Million
Q2 2022

Aug 15, 2022

BUY
$7.65 - $14.24 $1.51 Million - $2.81 Million
197,256 Added 31.99%
813,872 $8.27 Million
Q1 2022

Oct 27, 2022

SELL
$13.02 - $20.78 $2.57 Million - $4.1 Million
-197,256 Reduced 24.24%
616,616 $8.79 Million
Q1 2022

May 13, 2022

SELL
$13.02 - $20.78 $17.2 Million - $27.5 Million
-1,321,644 Reduced 68.19%
616,616 $8.79 Million
Q4 2021

Feb 14, 2022

BUY
$19.35 - $25.54 $21.9 Million - $28.9 Million
1,133,000 Added 140.7%
1,938,260 $40 Million
Q3 2021

Nov 15, 2021

BUY
$21.65 - $39.49 $17.4 Million - $31.8 Million
805,260 New
805,260 $18.4 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.